Pacira BioSciences, Inc. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 38.35 | 25,000 | 958,750 | 25,000 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 2,500 | 0 | 12,141 | 9.6 K to 12.1 K (+25.93 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 38.35 | 30,000 | 1,150,500 | 30,000 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 13,042 | 8 K to 13 K (+62.17 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 38.35 | 30,000 | 1,150,500 | 30,000 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 5,238 | 238 to 5.2 K (+2,100.84 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 782 | 0 | 24,319 | 23.5 K to 24.3 K (+3.32 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 782 | 0 | 5,927 | 5.1 K to 5.9 K (+15.20 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 782 | 0 | 7,577 | 6.8 K to 7.6 K (+11.51 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 782 | 0 | 3,529 | 2.7 K to 3.5 K (+28.47 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 782 | 0 | 5,627 | 4.8 K to 5.6 K (+16.14 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Grant | A | 0.00 | 782 | 0 | 882 | 100 to 882 (+782.00 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 782 | 0 | 4,627 | 3.8 K to 4.6 K (+20.34 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 38.35 | 47,250 | 1,812,038 | 47,250 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 7,875 | 0 | 27,147 | 19.3 K to 27.1 K (+40.86 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 38.35 | 170,250 | 6,529,088 | 170,250 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 28,375 | 0 | 110,415 | 82 K to 110.4 K (+34.59 %) |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | A | 38.35 | 47,250 | 1,812,038 | 47,250 | |
| Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Grant | A | 0.00 | 7,875 | 0 | 20,101 | 12.2 K to 20.1 K (+64.41 %) |
| Jun 08 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 37.53 | 2,600 | 97,578 | 82,040 | 84.6 K to 82 K (-3.07 %) |
| Jun 08 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 36.63 | 7,191 | 263,406 | 84,640 | 91.8 K to 84.6 K (-7.83 %) |
| Jun 08 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Sell | S | 35.61 | 8,615 | 306,780 | 91,831 | 100.4 K to 91.8 K (-8.58 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 33.02 | 2,040 | 67,361 | 19,272 | 21.3 K to 19.3 K (-9.57 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Sell | S | 33.02 | 373 | 12,316 | 5,088 | 5.5 K to 5.1 K (-6.83 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 33.02 | 1,367 | 45,138 | 12,226 | 13.6 K to 12.2 K (-10.06 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 33.02 | 801 | 26,449 | 9,641 | 10.4 K to 9.6 K (-7.67 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Sell | S | 33.02 | 708 | 23,378 | 8,042 | 8.8 K to 8 K (-8.09 %) |
| Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Sell | S | 33.90 | 771 | 26,137 | 2,747 | 3.5 K to 2.7 K (-21.92 %) |